EX-23.1 3 ff12019a1ex23-1_biondvax.htm CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER OF ERNST & YOUNG ISRAEL.

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption "Experts" and to the use of our report dated April 28, 2019, in the Registration Statement (Form F-1/A) and related Prospectus of Biondvax Pharmaceuticals Ltd., dated May 6, 2019.


Tel-Aviv, Israel		/s/ KOST FORER GABBAY & KASIERER
May 6, 2019		A Member of Ernst & Young Global